Anixa Biosciences, Inc. (ANIX) Financials
Key financial figures for Anixa Biosciences, Inc. (Q3 2026).
Anixa Biosciences, Inc. reported revenue of $0.00 for Q3 FY2026. The company posted a net loss of $2.6 million, or -$0.08 per share. Free cash flow for the period was -$1.8 million. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Anixa Biosciences, Inc. are on the SentiSense financials page.
- Revenue
- $0
- Net Income
- -$3M
- EPS
- $-0.08
- Total Assets
- $15M
- Operating Cash Flow
- -$2M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $0 | -$3M | -$0.08 | -$2M | |
| Q2 FY2026 | $0 | -$3M | -$0.07 | -$2M | |
| Q1 FY2026 | $0 | -$3M | -$0.08 | -$3M | |
| Q4 FY2025 | $0 | -$3M | -$0.08 | -$1M | |
| Q3 FY2025 | $0 | -$2M | -$0.07 | -$2M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $0 | -$11M | -$0.34 | -$7M | |
| FY2024 | $0 | -$13M | -$0.39 | -$7M | |
| FY2023 | $210K | -$10M | -$0.32 | -5243.33% | -$6M |
Frequently asked questions
What was Anixa Biosciences, Inc.'s revenue last quarter?
Anixa Biosciences, Inc. reported revenue of $0.00 for Q3 FY2026.
Is Anixa Biosciences, Inc. profitable?
Not in its most recent reported period. Anixa Biosciences, Inc. reported a net loss of $2.6 million for Q3 FY2026.
How much free cash flow did Anixa Biosciences, Inc. generate?
Anixa Biosciences, Inc. generated free cash flow of -$1.8 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Anixa Biosciences, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.